Literature DB >> 32551799

Genome-Wide Association Study: Functional Variant rs2076295 Regulates Desmoplakin Expression in Airway Epithelial Cells.

Yuan Hao1, Samuel Bates1, Hongmei Mou2, Jeong H Yun1, Betty Pham1, Jiangyuan Liu1, Weiliang Qiu1, Feng Guo1, Jarrett D Morrow1, Craig P Hersh1, Christopher J Benway1, Lu Gong1, Yihan Zhang2, Ivan O Rosas3, Michael H Cho1, Jin-Ah Park4, Peter J Castaldi1, Fei Du1, Xiaobo Zhou1.   

Abstract

Rationale: Genetic association studies have identified rs2076295 in association with idiopathic pulmonary fibrosis (IPF). We hypothesized that rs2076295 is the functional variant regulating DSP (desmoplakin) expression in human bronchial epithelial cells, and DSP regulates extracellular matrix-related gene expression and cell migration, which is relevant to IPF development.
Objectives: To determine whether rs2076295 regulates DSP expression and the function of DSP in airway epithelial cells.
Methods: Using CRISPR (clustered regularly interspaced short palindromic repeat)/Cas9 editing (including regional deletion, indel, CRISPR interference, and single-base editing), we modified rs2076295 and measured DSP expression in edited 16HBE14o- and primary airway epithelial cells. Cellular integrity, migration, and genome-wide gene expression changes were examined in 16HBE14o- single colonies with DSP knockout. The expression of DSP and its relevant matrix genes was measured by quantitative PCR and also analyzed in single-cell RNA-sequencing data from control and IPF lungs.Measurements and Main
Results: DSP is expressed predominantly in bronchial and alveolar epithelial cells, with reduced expression in alveolar epithelial cells in IPF lungs. The deletion of the DNA region-spanning rs2076295 led to reduced expression of DSP, and the edited rs2076295GG 16HBE14o- line has lower expression of DSP than the rs2076295TT lines. Knockout of DSP in 16HBE14o- cells decreased transepithelial resistance but increased cell migration, with increased expression of extracellular matrix-related genes, including MMP7 and MMP9. Silencing of MMP7 and MMP9 abolished increased migration in DSP-knockout cells.Conclusions: rs2076295 regulates DSP expression in human airway epithelial cells. The loss of DSP enhances extracellular matrix-related gene expression and promotes cell migration, which may contribute to the pathogenesis of IPF.

Entities:  

Keywords:  CRISPR/Cas9 genome-editing; DSP; bronchial epithelial cells; cell migration; rs2076295

Mesh:

Substances:

Year:  2020        PMID: 32551799      PMCID: PMC7605184          DOI: 10.1164/rccm.201910-1958OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  41 in total

Review 1.  Matrix metalloproteinases in lung diseases.

Authors:  Hiroyuki Ohbayashi
Journal:  Curr Protein Pept Sci       Date:  2002-08       Impact factor: 3.272

2.  Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.

Authors:  Kevin K Kim; Matthias C Kugler; Paul J Wolters; Liliane Robillard; Michael G Galvez; Alexis N Brumwell; Dean Sheppard; Harold A Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

3.  Large-scale imputation of epigenomic datasets for systematic annotation of diverse human tissues.

Authors:  Jason Ernst; Manolis Kellis
Journal:  Nat Biotechnol       Date:  2015-02-18       Impact factor: 54.908

Review 4.  Idiopathic pulmonary fibrosis.

Authors:  Antoni Xaubet; Julio Ancochea; María Molina-Molina
Journal:  Med Clin (Barc)       Date:  2016-12-18       Impact factor: 1.725

5.  Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.

Authors:  Imre Noth; Yingze Zhang; Shwu-Fan Ma; Dan Nicolae; Naftali Kaminski; Joe G N Garcia; Carlos Flores; Mathew Barber; Yong Huang; Steven M Broderick; Michael S Wade; Pirro Hysi; Joseph Scuirba; Thomas J Richards; Brenda M Juan-Guardela; Rekha Vij; MeiLan K Han; Fernando J Martinez; Karl Kossen; Scott D Seiwert; Jason D Christie
Journal:  Lancet Respir Med       Date:  2013-04-17       Impact factor: 30.700

6.  Detecting the Molecular System Signatures of Idiopathic Pulmonary Fibrosis through Integrated Genomic Analysis.

Authors:  Indu Gangwar; Nitesh Kumar Sharma; Ganesh Panzade; Supriya Awasthi; Anurag Agrawal; Ravi Shankar
Journal:  Sci Rep       Date:  2017-05-08       Impact factor: 4.379

Review 7.  Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease.

Authors:  Coline H M van Moorsel
Journal:  Curr Opin Pulm Med       Date:  2018-05       Impact factor: 3.155

8.  RNA-sequencing across three matched tissues reveals shared and tissue-specific gene expression and pathway signatures of COPD.

Authors:  Jarrett D Morrow; Robert P Chase; Margaret M Parker; Kimberly Glass; Minseok Seo; Miguel Divo; Caroline A Owen; Peter Castaldi; Dawn L DeMeo; Edwin K Silverman; Craig P Hersh
Journal:  Respir Res       Date:  2019-04-02

9.  Role of matrix metaloproteases in idiopathic pulmonary fibrosis.

Authors:  Annie Pardo; Moisés Selman
Journal:  Fibrogenesis Tissue Repair       Date:  2012-06-06

10.  Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs?

Authors:  Moisés Selman; Annie Pardo; Naftali Kaminski
Journal:  PLoS Med       Date:  2008-03-04       Impact factor: 11.069

View more
  7 in total

1.  Common idiopathic pulmonary fibrosis risk variants are associated with hypersensitivity pneumonitis.

Authors:  Haruhiko Furusawa; Anna L Peljto; Avram D Walts; Jonathan Cardwell; Philip L Molyneaux; Joyce S Lee; Evans R Fernández Pérez; Paul J Wolters; Ivana V Yang; David A Schwartz
Journal:  Thorax       Date:  2022-01-07       Impact factor: 9.102

2.  Desmoplakin: An Important Player in Aging Lung Disease.

Authors:  Coline H M van Moorsel
Journal:  Am J Respir Crit Care Med       Date:  2020-11-01       Impact factor: 21.405

Review 3.  Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis.

Authors:  Jacob E Michalski; David A Schwartz
Journal:  J Inflamm Res       Date:  2021-01-05

Review 4.  Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis.

Authors:  Qianru Mei; Zhe Liu; He Zuo; Zhenhua Yang; Jing Qu
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.810

5.  CRISPR interference interrogation of COPD GWAS genes reveals the functional significance of desmoplakin in iPSC-derived alveolar epithelial cells.

Authors:  Rhiannon B Werder; Tao Liu; Kristine M Abo; Jonathan Lindstrom-Vautrin; Carlos Villacorta-Martin; Jessie Huang; Anne Hinds; Nathan Boyer; Esther Bullitt; Marc Liesa; Edwin K Silverman; Darrell N Kotton; Michael H Cho; Xiaobo Zhou; Andrew A Wilson
Journal:  Sci Adv       Date:  2022-07-13       Impact factor: 14.957

6.  A refocus on the advances of single-cell biomedicine.

Authors:  William Wang; Xiangdong Wang
Journal:  Cell Biol Toxicol       Date:  2020-08-10       Impact factor: 6.691

Review 7.  Emerging Roles of Airway Epithelial Cells in Idiopathic Pulmonary Fibrosis.

Authors:  Ashesh Chakraborty; Michal Mastalerz; Meshal Ansari; Herbert B Schiller; Claudia A Staab-Weijnitz
Journal:  Cells       Date:  2022-03-19       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.